THE ITALIAN MULTICENTRIC RANDOMIZED OPTKIMA TRIAL ON FIXED VS PROGRESSIVE INTERMITTENT TKI THERAPY IN CML ELDERLY PATIENTS: 3-YEARS OF MOLECULAR RESPONSE AND QUALITY OF LIFE MONITORING AFTER COMPLETING THE TREATMENT PLAN. Michele Malagola , Alessandra Iurlo , Cristina Bucelli , Elisabetta Abruzzese , Massimiliano Bonifacio , Fabio Stagno , Gianni Binotto , Marienlla D'Adda , Monia Lunghi , Monica Crugnola , Maria Luisa Ferrari , Francesca Lunghi , Fausto Castagnetti , Gianantonio Rosti , Roerto Massimo Lemoli , Rosaria Sancetta , Maria Rosaria Coppi , Maria Teresa Corsetti , Marco De Gobbi , Atelda Romano , Mario Tiribelli , Antonella Russo Rossi , Sabina Russo , Marzia Defina , Mirko Farina , Simona Bernardi , Giulia Butturini , Simone Pellizzeri , Aldo Maria Roccaro , Domenico Russo CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2024）
关键词
Chronic myeloid leukemia, Health-Related Quality of Life (HRQoL), Intermittent, Tyrosine kinase inhibitor
AI 理解论文
溯源树
样例
